Futura Medical (FUM) — Capital Reinvestment Ratio

Latest as of December 2024: 0.26x

Futura Medical (FUM) has a Capital Reinvestment Ratio of 0.26x as of December 2024, meaning it reinvests 0% of its operating cash flow (GBX3.44 Million) in capital expenditures (GBX903.73K). See how leveraged is Futura Medical's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

GBX3.44 Million
GBX

Capital Expenditures

GBX903.73K
GBX

Data as of

Dec 2024
Most recent filing

Futura Medical Capital Reinvestment Ratio (2023–2024)

This chart tracks Futura Medical's Capital Reinvestment Ratio across 2 annual periods. Check Futura Medical cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Futura Medical (2023–2024)

Year-by-year Capital Reinvestment Ratio for Futura Medical from 2023 to 2024. For live market cap and broader valuation context, see Futura Medical (FUM) market capitalisation.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
2024 3.94x GBX438.41K GBX1.73 Million ▲ +49.2%
2023 2.64x GBX570.25K GBX1.51 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow